论文部分内容阅读
目的探讨降纤酶联合α-硫辛酸在急性脑梗死患者中的临床治疗效果及对日常生活活动能力的影响。方法 80例急性脑梗死患者,采用随机对照方法分为对照组和实验组,每组40例。对照组采用α-硫辛酸治疗,实验组在对照组基础上联合降纤酶治疗。比较两组临床疗效。结果两组患者治疗前神经功能缺损评分(NIHSS)、改良的Rankin量表评分(MRS)以及日常生活能力评定量表(Barthel指数)评分比较差异无统计学意义(P>0.05);实验组治疗后NIHSS评分、MRS评分显著低于对照组(P<0.05),Barthel评分显著高于对照组(P<0.05);两组患者治疗前活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)及纤维蛋白原(Fbg)比较差异无统计学意义(P>0.05);实验组治疗后APTT、PT显著高于对照组(P<0.05),Fbg显著低于对照组(P<0.05);实验组总有效率为87.5%,显著高于对照组的70.0%(P<0.05)。结论急性脑梗死患者在α-硫辛酸治疗基础上联合降纤酶治疗效果理想,能够提高临床效果,改善患者日常生活活动能力,值得临床推广应用。
Objective To investigate the clinical effect of defibrase combined with α-lipoic acid in patients with acute cerebral infarction and its effect on daily living activities. Methods Eighty patients with acute cerebral infarction were randomly divided into control group and experimental group with 40 cases in each group. The control group was treated with α-lipoic acid, and the experimental group was treated with defibrase on the basis of the control group. The clinical efficacy of the two groups were compared. Results There was no significant difference in NIHSS, MRS and Barthel index between the two groups before and after treatment (P> 0.05) The NIHSS score and MRS score of the two groups were significantly lower than those of the control group (P <0.05), and the Barthel score was significantly higher than that of the control group (P <0.05). The APTT and prothrombin time (P <0.05). The levels of APTT and PT in the experimental group were significantly higher than those in the control group (P <0.05), while the levels of Fbg in the experimental group were significantly lower than those in the control group (P <0.05) The total effective rate in experimental group was 87.5%, which was significantly higher than that in control group (70.0%, P <0.05). Conclusion Patients with acute cerebral infarction on the basis of α-lipoic acid combined with defibrase treatment effect is ideal, can improve clinical efficacy and improve patients’ daily living activities, worthy of clinical promotion and application.